IRON (Disc Medicine) Buyback Yield %: -7.42 (As of Jul. 04, 2026)


IRON Disc Medicine Inc IRON
34 GF Score
Price $76.26
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Buyback Yield %?

Disc Medicine IRON +1.73% 34 Buyback Yield % is -7.42 as of Jul. 04, 2026. GuruFocus rates IRON with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 744 Biotechnology companies, Disc Medicine ranks better than 52.69% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Disc Medicine's current buyback yield was -7.42%.

Disc Medicine Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Disc Medicine's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disc Medicine Buyback Yield % Chart

Disc Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 -15.46 -14.15 -9.89 -14.96

Disc Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.68 -12.73 -10.54 -14.96 -8.85

IRON vs CLDX, TARS, KLRA: Buyback Yield % Comparison

For the Biotechnology subindustry, Disc Medicine's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Disc Medicine Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Disc Medicine's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Disc Medicine's Buyback Yield % falls into.


IRON
34GF Score
Disc Medicine Inc IRON
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Disc Medicine's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 450.112) / 3008.92431
=-14.96%

Disc Medicine's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 216.109) / 2441.8686
=-8.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -7.42 mean?
Disc Medicine (IRON) has a Buyback Yield % of -7.42 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Disc Medicine and its competitors. According to the industry distribution chart, Disc Medicine ranks #352 out of 744 companies in the Biotechnology industry, placing it in the top 47.3%.
Is Disc Medicine's Buyback Yield % too high?
Disc Medicine's current Buyback Yield % is -7.42. Based on the distribution chart, Disc Medicine ranks #352 out of 744 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Disc Medicine has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's Buyback Yield % compare to CLDX and TARS?
According to the Biotechnology industry distribution chart, Disc Medicine ranks #352 out of 744 companies for Buyback Yield %. This puts Disc Medicine in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Disc Medicine and its competitors. Disc Medicine's current Buyback Yield % is -7.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current Buyback Yield % of -7.42. The current Buyback Yield % is -7.42. Disc Medicine's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Disc Medicine (IRON), the current Buyback Yield % is -7.42 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.26
Price